Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Physiol Rep ; 12(10): e16056, 2024 May.
Article de Anglais | MEDLINE | ID: mdl-38777811

RÉSUMÉ

Permeability transition pore (PTP) opening dissipates ion and electron gradients across the internal mitochondrial membrane (IMM), including excess Ca2+ in the mitochondrial matrix. After opening, immediate PTP closure must follow to prevent outer membrane disruption, loss of cytochrome c, and eventual apoptosis. Flickering, defined as the rapid alternative opening/closing of PTP, has been reported in heart, which undergoes frequent, large variations in Ca2+. In contrast, in tissues that undergo depolarization events less often, such as the liver, PTP would not need to be as dynamic and thus these tissues would not be as resistant to stress. To evaluate this idea, it was decided to follow the reversibility of the permeability transition (PT) in isolated murine mitochondria from two different tissues: the very dynamic heart, and the liver, which suffers depolarizations less frequently. It was observed that in heart mitochondria PT remained reversible for longer periods and at higher Ca2+ loads than in liver mitochondria. In all cases, Ca2+ uptake was inhibited by ruthenium red and PT was delayed by Cyclosporine A. Characterization of this phenomenon included measuring the rate of oxygen consumption, organelle swelling and Ca2+ uptake and retention. Results strongly suggest that there are tissue-specific differences in PTP physiology, as it resists many more Ca2+ additions before opening in a highly active organ such as the heart than in an organ that seldom suffers Ca2+ loading, such as the liver.


Sujet(s)
Calcium , Mitochondries du myocarde , Mitochondries du foie , Protéines de transport de la membrane mitochondriale , Pore de transition de perméabilité mitochondriale , Rat Wistar , Animaux , Pore de transition de perméabilité mitochondriale/métabolisme , Mâle , Calcium/métabolisme , Mitochondries du myocarde/métabolisme , Mitochondries du foie/métabolisme , Protéines de transport de la membrane mitochondriale/métabolisme , Rats , Consommation d'oxygène , Foie/métabolisme , Gonflement mitochondrial/effets des médicaments et des substances chimiques , Ciclosporine/pharmacologie
2.
Nanotoxicology ; 18(2): 122-133, 2024 Mar.
Article de Anglais | MEDLINE | ID: mdl-38436290

RÉSUMÉ

Food-grade titanium dioxide (E171) and zinc oxide nanoparticles (ZnO NPs) are found in diverse products for human use. E171 is used as whitening agent in food and cosmetics, and ZnO NPs in food packaging. Their potential multi-organ toxicity has raised concerns on their safety. Since mitochondrial dysfunction is a key aspect of cardio-pathologies, here, we evaluate the effect of chronic exposure to E171 and ZnO NPs in rats on cardiac mitochondria. Changes in cardiac electrophysiology and body weight were measured. E171 reduced body weight more than 10% after 5 weeks. Both E171 and ZnO NPs increased systolic blood pressure (SBP) from 110-120 to 120-140 mmHg after 45 days of treatment. Both NPs altered the mitochondrial permeability transition pore (mPTP), reducing calcium requirement for permeability by 60% and 93% in E171- and ZnO NPs-exposed rats, respectively. Treatments also affected conformational state of adenine nucleotide translocase (ANT). E171 reduced the binding of EMA to Cys 159 in 30% and ZnO NPs in 57%. Mitochondrial aconitase activity was reduced by roughly 50% with both NPs, indicating oxidative stress. Transmission electron microscopy (TEM) revealed changes in mitochondrial morphology including sarcomere discontinuity, edema, and hypertrophy in rats exposed to both NPs. In conclusion, chronic oral exposure to NPs induces functional and morphological damage in cardiac mitochondria, with ZnO NPs being more toxic than E171, possibly due to their dissociation in free Zn2+ ion form. Therefore, chronic intake of these food additives could increase risk of cardiovascular disease.


Sujet(s)
Mitochondries du myocarde , Titane , Oxyde de zinc , Animaux , Titane/toxicité , Oxyde de zinc/toxicité , Oxyde de zinc/composition chimique , Mitochondries du myocarde/effets des médicaments et des substances chimiques , Mitochondries du myocarde/métabolisme , Mâle , Rats , Administration par voie orale , Perméabilité/effets des médicaments et des substances chimiques , Pore de transition de perméabilité mitochondriale/métabolisme , Nanoparticules métalliques/toxicité , Nanoparticules/toxicité , Nanoparticules/composition chimique , Rat Sprague-Dawley , Protéines de transport de la membrane mitochondriale/métabolisme , Protéines de transport de la membrane mitochondriale/effets des médicaments et des substances chimiques , Pression sanguine/effets des médicaments et des substances chimiques
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE